A39.4
Meningococcemia, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Meningococcemia is a serious bloodstream infection caused by the bacteria Neisseria meningitidis. When the infection affects the blood without a specified location or additional complications, it is classified under the ICD-10 code A39.4. This condition can progress rapidly and requires prompt medical attention to prevent severe health issues or death. Meningococcemia can also lead to other complications such as meningitis, which is inflammation of the membranes surrounding the brain and spinal cord.
Causes & Symptoms
Clinical Causes: Infection with Neisseria meningitidis bacteria Close contact with an infected person, such as living in the same household or sharing respiratory secretions Inadequate vaccination history against meningococcal disease Young age, especially infants and adolescents Compromised immune system due to illness or medical treatments
Key Symptoms: Sudden onset of high fever Rapid breathing and increased heart rate Vomiting and abdominal pain Weakness, fatigue, and malaise Signs of shock, such as cold extremities and low blood pressure Dark patches or purpura on the skin, indicating bleeding into the skin Headache, neck stiffness, and sensitivity to light if meningitis develops Confusion or altered mental state
Diagnostic & Treatment
Diagnosis Path: Diagnosing meningococcemia involves a combination of clinical examination and laboratory tests. Blood samples are typically taken to identify the presence of Neisseria meningitidis bacteria. Additional tests, such as blood cultures, quick antigen tests, and cerebrospinal fluid analysis if meningitis symptoms appear, may be performed. Early diagnosis is critical because of the rapid progression and potential severity of the disease.
Treatment Protocols: Treatment generally requires urgent hospitalization. Antibiotics are the mainstay of therapy to eliminate the bacterial infection, often administered intravenously. Supportive care, including fluids, medications to manage shock, and oxygen therapy, may be necessary. Close monitoring is essential to manage complications and to determine if there’s involvement of the meninges, which may necessitate additional treatments like corticosteroids or specific therapies for meningitis.
Clinical Advice & FAQs
Billing Guidance
Is A39.4 a billable ICD-10 code?
Yes, A39.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A39.4?
Clinical documentation must specify the nature of Meningococcemia, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
